PharmaEngine (4162) — Working Capital to Net Assets Ratio
PharmaEngine (4162) has a Working Capital to Net Assets ratio of 99.6% as of September 2025. Working capital of NT$4.78 Billion (current assets of NT$4.89 Billion minus current liabilities of NT$112.33 Million) is measured against net assets of NT$4.79 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 4162 net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
PharmaEngine Working Capital to Net Assets (2009–2024)
This chart shows how PharmaEngine's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2009 to 2024. As of September 2025, the ratio stands at 99.6%, reflecting working capital of NT$4.78 Billion against net assets of NT$4.79 Billion TWD. Check 4162 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for PharmaEngine (2009–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for PharmaEngine from 2009 to 2024, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 4162 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 99.7% | NT$5.38 Billion | NT$5.40 Billion | NT$5.83 Billion | NT$443.05 Million | ▲ +0.3 pp |
| 2023 | 99.4% | NT$3.84 Billion | NT$3.86 Billion | NT$3.92 Billion | NT$83.86 Million | ▲ +0.0 pp |
| 2022 | 99.4% | NT$3.85 Billion | NT$3.87 Billion | NT$3.93 Billion | NT$78.74 Million | ▼ -0.2 pp |
| 2021 | 99.6% | NT$3.92 Billion | NT$3.94 Billion | NT$4.01 Billion | NT$87.70 Million | ▲ +0.2 pp |
| 2020 | 99.4% | NT$3.99 Billion | NT$4.01 Billion | NT$4.17 Billion | NT$184.46 Million | ▲ +0.6 pp |
| 2019 | 98.8% | NT$3.44 Billion | NT$3.48 Billion | NT$3.58 Billion | NT$138.44 Million | ▼ -0.5 pp |
| 2018 | 99.3% | NT$3.67 Billion | NT$3.69 Billion | NT$3.82 Billion | NT$152.67 Million | ▲ +0.3 pp |
| 2017 | 99.0% | NT$3.87 Billion | NT$3.91 Billion | NT$4.07 Billion | NT$199.90 Million | ▼ -0.7 pp |
| 2016 | 99.7% | NT$3.79 Billion | NT$3.80 Billion | NT$3.94 Billion | NT$150.04 Million | ▲ +1.6 pp |
| 2015 | 98.0% | NT$3.10 Billion | NT$3.16 Billion | NT$3.16 Billion | NT$66.34 Million | ▼ -0.9 pp |
| 2014 | 99.0% | NT$2.90 Billion | NT$2.93 Billion | NT$2.91 Billion | NT$18.02 Million | ▼ -0.1 pp |
| 2013 | 99.1% | NT$2.69 Billion | NT$2.72 Billion | NT$2.72 Billion | NT$25.80 Million | ▼ -1.0 pp |
| 2012 | 100.1% | NT$1.63 Billion | NT$1.63 Billion | NT$1.65 Billion | NT$11.66 Million | ▼ -0.1 pp |
| 2011 | 100.1% | NT$619.28 Million | NT$618.48 Million | NT$632.19 Million | NT$12.90 Million | ▼ -1.2 pp |
| 2010 | 101.4% | NT$82.52 Million | NT$81.42 Million | NT$93.53 Million | NT$11.01 Million | ▲ +1.6 pp |
| 2009 | 99.8% | NT$11.27 Million | NT$11.29 Million | NT$38.77 Million | NT$27.50 Million | — |